RTI Biologics是一家利用自然组织和技术来修补和促进自然愈合人体骨骼和其它人体组织，并改善自然回复能力方面的领导商，包括骨头、软骨、腱、韧带、皮肤和心血管组织。该公司所研发的移植物具有足够的结构稳定性和生物相容性，因此为外科医师提供了自体移植、同种异体移植和合成可吸收材料之外的另一种选择。

 
RTI Biologics Inc. is a leading provider of sterile biologic implants for surgeries around the world with a commitment to advancing science, safety and innovation. RTI prepares human donated tissue and animal tissue for transplantation through extensive testing and screening, precision shaping and using proprietary, validated processes. These allograft and xenograft implants are used in orthopedic, dental and other specialty surgeries.

RTI's innovations continuously raise the bar of science and safety for biologics - from being the first company to offer precision-tooled bone implants and assembled technology to maximize each gift of donation, to inventing validated sterilization processes that include viral inactivation steps. These processes -- BioCleanse(R), Tutoplast(R) and Cancelle(TM) SP DBM -- have a combined record of more than five million implants sterilized with zero incidence of implant-associated infection. These processes have been validated by tissue type to inactivate or remove viruses, bacteria, fungi and spores from the tissue while maintaining biocompatibility and functionality.

RTI's worldwide corporate headquarters are located in Alachua, Fla., with international locations in Germany and France. The company is accredited by the American Association of Tissue Banks in the United States and is a member of AdvaMed.